| 100785-5 |
Feeling people dislike me |
Find |
^Patient |
RptPeriod |
Ord |
|
|
ACTIVE |
Feeling people dislike me |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
100785-5 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100786-3 |
Lack of energy |
Find |
^Patient |
RptPeriod |
Ord |
|
|
ACTIVE |
Lack of energy |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
100786-3 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100787-1 |
Total Score |
Score |
^Patient |
RptPeriod |
Qn |
CES-D |
|
ACTIVE |
Total Score CES-D |
|
ADD |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
100787-1 |
|
CES-D |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Dextro; QNT; Quan; Quant; Quantitative; Report period; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl |
2.73 |
2.73 |
|
|
|
|
|
|
|
{score} |
|
|
|
0 |
| 100788-9 |
Stemphylium botryosum Ab.IgG4 |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
100788-9 |
|
|
|
|
Both |
|
|
|
0 |
S botryosum IgG4-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; m10; Mass concentration; Pleospora tarda; Point in time; QNT; Quan; Quant; Quantitative; Random; S botryosum; Serum; SR; Stemphylium botryosum IgG4 |
2.73 |
2.73 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 100789-7 |
Rhizopus nigricans Ab.IgG4 |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
100789-7 |
|
|
|
|
Both |
|
|
|
0 |
R nigricans IgG4-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; m11; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; R nigricans; Random; Rhizopus nigricans IgG4; Serum; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 10079-2 |
S' wave duration.lead V4 |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
S' wave duration in lead V4 |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
EKG.MEAS |
|
10079-2 |
|
EKG |
|
|
Observation |
|
|
|
0 |
S' wave dur L-V4 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S' wave dur L-V4; S wave dur L-V4 |
2.48 |
1.0i |
|
|
|
|
|
|
|
s |
|
|
|
0 |
| 100790-5 |
Lepidoglyphus destructor Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
100790-5 |
|
|
|
|
Both |
|
|
|
0 |
L destructor IgG-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; d071; d71; Immune globulin G; Immunoglobulin G; L destructor; Lepidoglyphus destructor IgG; Level; Mass concentration; Mite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Storage mite |
2.73 |
2.73 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 100791-3 |
Hamster epithelium Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Hamster epithelium IgG Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
100791-3 |
|
|
|
|
Both |
|
|
|
0 |
Hmtr Epith IgG-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e084; e84; Epithelia; Golden hamster epithelium; Hamster epithelium IgG; Hmtr Epith; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 100792-1 |
Forsythia Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Forsythia IgE Ab [Units/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
kU/L |
|
|
|
|
|
|
ALLERGY |
|
100792-1 |
|
|
|
|
Both |
|
|
|
0 |
Forsythia IgE Qn |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Forsythia IgE; golden bell; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
kU/L |
|
|
|
0 |
| 100793-9 |
Testosterone |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Testosterone [Mass/volume] in Body fluid |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
100793-9 |
|
|
|
|
Both |
|
|
|
0 |
Testost Fld-mCnc |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CHEMISTRY.CHALLENGE TESTING; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Testo; Testos; Testost |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 100794-7 |
Follitropin |
ACnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Follitropin [Units/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
mUI/mL |
|
|
|
|
|
|
CHEM |
|
100794-7 |
|
|
|
|
Both |
|
|
|
0 |
FSH Fld-aCnc |
|
|
|
N |
|
Arbitrary concentration; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Follicle stimulating hormone; FSH; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.74 |
2.73 |
|
|
|
|
|
|
|
[IU]/L;m[IU]/mL |
|
|
|
0 |
| 100795-4 |
S100 calcium binding protein B |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
S100 calcium binding protein B [Mass/volume] in Body fluid |
|
ADD |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
CHEM |
|
100795-4 |
|
|
|
|
Both |
|
|
|
0 |
S100 Ca binding protein B Fld-mCnc |
|
|
|
N |
|
B/F; BF; Bind; bod; Bodies; Body fluid; Body fluid, unsp; Ca; Cal; Chemistry; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; S100 Ca binding protein B; S-100B; S-100-beta |
2.73 |
2.73 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 100796-2 |
Thyroglobulin |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Thyroglobulin [Mass/volume] in Body fluid |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
SERO |
|
100796-2 |
|
|
|
|
Both |
|
|
|
0 |
Thyroglob Fld-mCnc |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Tg; Thyglobulin; Thyroglbn; Thyroglob; Tumor marker |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 100797-0 |
Testosterone.free^1st specimen post XXX challenge |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
100797-0 |
|
|
|
|
Both |
|
|
|
0 |
Testost Free sp1 p chal Ser-mCnc |
|
|
|
N |
|
Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; First; FR; Level; Mass concentration; Non-protein bound; p chal; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; Serum; sp1; sp1 p chal; Spec; SR; Testo; Testos; Testost; Testost Free; Testosterone.unconjugated |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 100798-8 |
Testosterone.free^2nd specimen post XXX challenge |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
100798-8 |
|
|
|
|
Both |
|
|
|
0 |
Testost Free sp2 p chal Ser-mCnc |
|
|
|
N |
|
After; CHEMISTRY.CHALLENGE TESTING; Convalescent; FR; Level; Mass concentration; Non-protein bound; p chal; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; Serum; sp2; sp2 p chal; Spec; SR; Testo; Testos; Testost; Testost Free; Testosterone.unconjugated |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 100799-6 |
21-Deoxycortisol^1st specimen post XXX challenge |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
100799-6 |
|
|
|
|
Both |
|
|
|
0 |
21DC sp1 p chal Ser-mCnc |
|
|
|
N |
|
21DC; 21-DF; Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; First; Level; Mass concentration; p chal; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; Serum; sp1; sp1 p chal; Spec; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 1008-2 |
Indirect antiglobulin test.polyspecific reagent |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1008-2 |
|
|
|
|
Observation |
|
|
|
0 |
IAT Poly-Sp Reag SerPl Ql |
|
|
|
|
|
Antiglob; BLOOD BANK; Hematology; Heme; IAGT; IAT; IAT Poly-Sp Reag; IDC; Ind; Ind Coombs; Indir; Indirect Coomb; Indirect Coombs; Ordinal; Pl; Plasma; Plsm; Point in time; poly specific; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
Release 2.70: COMPONENT: Updated "poly specific" to one word (no space).; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 10080-0 |
S' wave duration.lead V5 |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
S' wave duration in lead V5 |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
EKG.MEAS |
|
10080-0 |
|
EKG |
|
|
Observation |
|
|
|
0 |
S' wave dur L-V5 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S' wave dur L-V5; S wave dur L-V5 |
2.48 |
1.0i |
|
|
|
|
|
|
|
s |
|
|
|
0 |
| 100800-2 |
21-Deoxycortisol^2nd specimen post XXX challenge |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
100800-2 |
|
|
|
|
Both |
|
|
|
0 |
21DC sp2 p chal Ser-mCnc |
|
|
|
N |
|
21DC; 21-DF; After; CHEMISTRY.CHALLENGE TESTING; Convalescent; Level; Mass concentration; p chal; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; Serum; sp2; sp2 p chal; Spec; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 100801-0 |
21-Deoxycortisol^3rd specimen post XXX challenge |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
100801-0 |
|
|
|
|
Observation |
|
|
|
0 |
21DC sp3 p chal Ser-mCnc |
|
|
|
N |
|
21DC; 21-DF; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Serum; sp3; sp3 p chal; Spec; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 100802-8 |
21-Deoxycortisol^4th specimen post XXX challenge |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
100802-8 |
|
|
|
|
Both |
|
|
|
0 |
21DC sp4 p chal Ser-mCnc |
|
|
|
N |
|
21DC; 21-DF; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Serum; sp4; sp4 p chal; Spec; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 100803-6 |
21-Deoxycortisol^5th specimen post XXX challenge |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
100803-6 |
|
|
|
|
Both |
|
|
|
0 |
21DC sp5 p chal Ser-mCnc |
|
|
|
N |
|
21DC; 21-DF; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Serum; sp5; sp5 p chal; Spec; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 100804-4 |
Vasopressin^1st specimen post XXX challenge |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
100804-4 |
|
|
|
|
Both |
|
|
|
0 |
Vasopressin sp1 p chal Plas-sCnc |
|
|
|
N |
|
Acute specimen; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; First; Level; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; sp1; sp1 p chal; Spec; Substance concentration; VP |
2.73 |
2.73 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 100805-1 |
Vasopressin^2nd specimen post XXX challenge |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
100805-1 |
|
|
|
|
Both |
|
|
|
0 |
Vasopressin sp2 p chal Plas-sCnc |
|
|
|
N |
|
ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Convalescent; Level; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; sp2; sp2 p chal; Spec; Substance concentration; VP |
2.73 |
2.73 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 100806-9 |
Vasopressin^3rd specimen post XXX challenge |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
100806-9 |
|
|
|
|
Both |
|
|
|
0 |
Vasopressin sp3 p chal Plas-sCnc |
|
|
|
N |
|
ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp3; sp3 p chal; Spec; Substance concentration; VP |
2.73 |
2.73 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |